Literature DB >> 24067963

SAMHD1 restricts herpes simplex virus 1 in macrophages by limiting DNA replication.

Eui Tae Kim1, Tommy E White, Alberto Brandariz-Núñez, Felipe Diaz-Griffero, Matthew D Weitzman.   

Abstract

Macrophages play important roles in host immune defense against virus infection. During infection by herpes simplex virus 1 (HSV-1), macrophages acquire enhanced antiviral potential. Restriction of HSV-1 replication and progeny production is important to prevent viral spread, but the cellular mechanisms that inhibit the DNA virus in macrophages are unknown. SAMHD1 was recently identified as a retrovirus restriction factor highly expressed in macrophages. The SAMHD1 protein is expressed in both undifferentiated monocytes and differentiated macrophages, but retroviral restriction is limited to differentiated cells by modulation of SAMHD1 phosphorylation. It is proposed to block reverse transcription of retroviral RNA into DNA by depleting cellular deoxynucleotide triphosphates (dNTPs). Viruses with DNA genomes do not employ reverse transcription during infection, but replication of their viral genomes is also dependent on intracellular dNTP concentrations. Here, we demonstrate that SAMHD1 restricts replication of the HSV-1 DNA genome in differentiated macrophage cell lines. Depleting SAMHD1 in THP-1 cells enhanced HSV-1 replication, while ectopic overexpression of SAMHD1 in U937 cells repressed HSV-1 replication. SAMHD1 did not impact viral gene expression from incoming HSV-1 viral genomes. HSV-1 restriction involved the dNTP triphosphohydrolase activity of SAMHD1 and was partially overcome by addition of exogenous deoxynucleosides. Unlike retroviruses, restriction of HSV-1 was not affected by SAMHD1 phosphorylation status. Our results suggest that SAMHD1 functions broadly to inhibit replication of DNA viruses in nondividing macrophages.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24067963      PMCID: PMC3838123          DOI: 10.1128/JVI.02291-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Genetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivo.

Authors:  Rodolphe Suspène; Marie-Ming Aynaud; Stefanie Koch; David Pasdeloup; Marc Labetoulle; Barbara Gaertner; Jean-Pierre Vartanian; Andreas Meyerhans; Simon Wain-Hobson
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

Review 2.  Intrinsic cellular defense mechanisms targeting human cytomegalovirus.

Authors:  Nina Tavalai; Thomas Stamminger
Journal:  Virus Res       Date:  2010-10-08       Impact factor: 3.303

3.  IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection.

Authors:  Nagaraj Kerur; Mohanan Valiya Veettil; Neelam Sharma-Walia; Virginie Bottero; Sathish Sadagopan; Pushpalatha Otageri; Bala Chandran
Journal:  Cell Host Microbe       Date:  2011-05-19       Impact factor: 21.023

Review 4.  Role of promyelocytic leukemia protein in host antiviral defense.

Authors:  Marie-Claude Geoffroy; Mounira K Chelbi-Alix
Journal:  J Interferon Cytokine Res       Date:  2011-01-03       Impact factor: 2.607

5.  Human immunodeficiency virus type 1 modified to package Simian immunodeficiency virus Vpx efficiently infects macrophages and dendritic cells.

Authors:  Nicole Sunseri; Meagan O'Brien; Nina Bhardwaj; Nathaniel R Landau
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

6.  HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase.

Authors:  David C Goldstone; Valerie Ennis-Adeniran; Joseph J Hedden; Harriet C T Groom; Gillian I Rice; Evangelos Christodoulou; Philip A Walker; Geoff Kelly; Lesley F Haire; Melvyn W Yap; Luiz Pedro S de Carvalho; Jonathan P Stoye; Yanick J Crow; Ian A Taylor; Michelle Webb
Journal:  Nature       Date:  2011-11-06       Impact factor: 49.962

7.  SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx.

Authors:  Nadine Laguette; Bijan Sobhian; Nicoletta Casartelli; Mathieu Ringeard; Christine Chable-Bessia; Emmanuel Ségéral; Ahmad Yatim; Stéphane Emiliani; Olivier Schwartz; Monsef Benkirane
Journal:  Nature       Date:  2011-05-25       Impact factor: 49.962

8.  The intrinsic antiviral defense to incoming HSV-1 genomes includes specific DNA repair proteins and is counteracted by the viral protein ICP0.

Authors:  Caroline E Lilley; Mira S Chaurushiya; Chris Boutell; Roger D Everett; Matthew D Weitzman
Journal:  PLoS Pathog       Date:  2011-06-16       Impact factor: 6.823

9.  Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein.

Authors:  Kasia Hrecka; Caili Hao; Magda Gierszewska; Selene K Swanson; Malgorzata Kesik-Brodacka; Smita Srivastava; Laurence Florens; Michael P Washburn; Jacek Skowronski
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

10.  SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection.

Authors:  André Berger; Andreas F R Sommer; Jenny Zwarg; Matthias Hamdorf; Karin Welzel; Nicole Esly; Sylvia Panitz; Andreas Reuter; Irene Ramos; Asavari Jatiani; Lubbertus C F Mulder; Ana Fernandez-Sesma; Frank Rutsch; Viviana Simon; Renate König; Egbert Flory
Journal:  PLoS Pathog       Date:  2011-12-08       Impact factor: 6.823

View more
  72 in total

1.  Structural Insights into the High-efficiency Catalytic Mechanism of the Sterile α-Motif/Histidine-Aspartate Domain-containing Protein.

Authors:  Yanhong Li; Jia Kong; Xin Peng; Wen Hou; Xiaohong Qin; Xiao-Fang Yu
Journal:  J Biol Chem       Date:  2015-10-05       Impact factor: 5.157

Review 2.  Reprogramming of cellular metabolic pathways by human oncogenic viruses.

Authors:  John G Purdy; Micah A Luftig
Journal:  Curr Opin Virol       Date:  2019-11-22       Impact factor: 7.090

3.  SAMHD1 Impairs HIV-1 Gene Expression and Negatively Modulates Reactivation of Viral Latency in CD4+ T Cells.

Authors:  Jenna M Antonucci; Sun Hee Kim; Corine St Gelais; Serena Bonifati; Tai-Wei Li; Olga Buzovetsky; Kirsten M Knecht; Alice A Duchon; Yong Xiong; Karin Musier-Forsyth; Li Wu
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

4.  Structural basis of cellular dNTP regulation by SAMHD1.

Authors:  Xiaoyun Ji; Chenxiang Tang; Qi Zhao; Wei Wang; Yong Xiong
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

5.  GTP activator and dNTP substrates of HIV-1 restriction factor SAMHD1 generate a long-lived activated state.

Authors:  Erik C Hansen; Kyle J Seamon; Shannen L Cravens; James T Stivers
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-21       Impact factor: 11.205

6.  Impaired dNTPase activity of SAMHD1 by phosphomimetic mutation of Thr-592.

Authors:  Chenxiang Tang; Xiaoyun Ji; Li Wu; Yong Xiong
Journal:  J Biol Chem       Date:  2015-08-20       Impact factor: 5.157

7.  SAMHD1 Modulates Early Steps during Human Cytomegalovirus Infection by Limiting NF-κB Activation.

Authors:  Eui Tae Kim; Kathryn L Roche; Katarzyna Kulej; Lynn A Spruce; Steven H Seeholzer; Donald M Coen; Felipe Diaz-Griffero; Eain A Murphy; Matthew D Weitzman
Journal:  Cell Rep       Date:  2019-07-09       Impact factor: 9.423

8.  A Putative Cyclin-binding Motif in Human SAMHD1 Contributes to Protein Phosphorylation, Localization, and Stability.

Authors:  Corine St Gelais; Sun Hee Kim; Lingmei Ding; Jacob S Yount; Dmitri Ivanov; Paul Spearman; Li Wu
Journal:  J Biol Chem       Date:  2016-11-04       Impact factor: 5.157

9.  Low dNTP levels are necessary but may not be sufficient for lentiviral restriction by SAMHD1.

Authors:  Sarah Welbourn; Klaus Strebel
Journal:  Virology       Date:  2015-12-04       Impact factor: 3.616

10.  Quantitative Proteomic Approach Identifies Vpr Binding Protein as Novel Host Factor Supporting Influenza A Virus Infections in Human Cells.

Authors:  Anne Sadewasser; Katharina Paki; Katrin Eichelbaum; Boris Bogdanow; Sandra Saenger; Matthias Budt; Markus Lesch; Klaus-Peter Hinz; Andreas Herrmann; Thomas F Meyer; Alexander Karlas; Matthias Selbach; Thorsten Wolff
Journal:  Mol Cell Proteomics       Date:  2017-03-13       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.